Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Ligand-gated Ion Channels

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sex differences in long-term survival of COPD patients following initiation of home non-invasive ventilation after acute hospitalization due to respiratory failure.

Respiration; international review of thoracic diseases·2026

Same author

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026

Same author

Enhanced fatty acid availability rewires fibroblasts metabolism and decreases collagen deposition in lung fibrosis.

Cellular and molecular life sciences : CMLS·2026

Same author

BK channels are indispensable for endothelial function in small pulmonary arteries.

Cell communication and signaling : CCS·2025

Same author

[Pathobiology and Genetics].

Pneumologie (Stuttgart, Germany)·2025

Same author

Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPD.

Lung·2025

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Targeting TASK-1 channels as a therapeutic approach.

Andrea Olschewski¹

¹University Clinic of Anesthesia and Intensive Care Medicine, Medical University of Graz, Auenbruggerplatz 29, A-8036, Graz, Austria. andrea.olschewski@meduni-graz.at

Advances in Experimental Medicine and Biology

|March 6, 2010

Summary

The TASK-1 potassium channel influences blood vessel tone and is crucial for regulating pulmonary artery responses to factors like hypoxia and anesthetics. It offers potential therapeutic targets for circulatory diseases.

More Related Videos

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Related Experiment Videos

Last Updated: Jun 15, 2026

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

Area of Science:

Physiology
Molecular Biology
Pharmacology

Background:

The TASK-1 (two-pore domain potassium channel subfamily 3 member 1) channel is a voltage-independent background K+ channel.
TASK-1 establishes the resting membrane potential in excitable cells, influencing cellular sensitivity to vasoactive agents.
TASK-1 channels are present in human pulmonary artery smooth muscle cells.

Purpose of the Study:

To investigate the role of TASK-1 channels in regulating pulmonary vascular tone.
To explore TASK-1's involvement in hypoxic pulmonary vasoconstriction and anesthetic-induced vasodilation.
To evaluate TASK-1 as a potential therapeutic target for pulmonary circulation diseases.

Main Methods:

The study focuses on the known functions and regulation of TASK-1 channels.
Evidence for TASK-1 presence and function in pulmonary artery smooth muscle cells is reviewed.
The impact of physiological factors (hypoxia, pH) and pharmacological agents (inhaled anesthetics, G protein-coupled pathways) on TASK-1 activity is discussed.

Main Results:

TASK-1 channels regulate pulmonary vascular tone through modulation by hypoxia, pH, and anesthetics.
TASK-1 plays a significant role in hypoxic pulmonary vasoconstriction.
TASK-1 activation by volatile anesthetics contributes to anesthetic-induced pulmonary vasodilation.
TASK-1 exhibits unique pH sensitivity, offering protective effects on pulmonary arteries.
TASK-1 mediates vasoactive responses in resistance arteries via G protein-coupled pathways.

Conclusions:

TASK-1 channels are critical regulators of pulmonary vascular tone and responses.
TASK-1's sensitivity to pH and its role in hypoxic vasoconstriction highlight its importance in pulmonary artery function.
Targeting TASK-1 presents promising therapeutic strategies for pulmonary vascular diseases.